SCHEMBL19329318

SCHEMBL19329318

NC(=O)c1cc(S(=O)(=O)Nc2ccc3[nH]ncc3c2)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 2/20 0.68
ACLY P53396 1/20 0.51
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
MAPK1 P28482 1/20 0.49
ALDH1A1 P00352 3/20 0.48
ROCK2 O75116 3/20 0.46
ROCK1 Q13464 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SYK P43405 2/20 0.45
KDR P35968 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19329451 0.91 CASP6 (0.82) CASP6MEN1KMT2AALDH1A1CYP1A2
SCHEMBL19329634 0.82 HDAC3 (0.53) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329690 0.80 ALDH1A1 (0.48) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329488 0.79 CASP6 (0.50) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329406 0.79 ALDH1A1 (0.75) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329572 0.78 MEN1 (0.51) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329447 0.78 ALDH1A1 (0.53) CASP6ACLYMEN1KMT2AMAPK1
SCHEMBL19329412 0.78 CASP6 (0.48) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329860 0.77 HTR6 (0.62) CASP6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL19329385 0.77 ALDH1A1 (0.56) CASP6MEN1KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017153952-A1 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-09-14 WO claimed
WO-2017153952-A1 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-09-14 WO disclosed